Human platelet eye drops for moderate to severe dry eye
Part of Eyes & vision clinical trials.
This study tests an eye drop made from human platelets (the cells that help healing) to see if it reduces dry eye symptoms better than a placebo. It is for people with moderate to severe dry eye.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had dry eye symptoms for the past 6 months.
- You have moderate to severe dry eye, confirmed by an eye exam (corneal staining and dryness score).
- You are willing to have both eyes treated and stop using contacts and other dry eye treatments during the study.
- You have not had eye surgery recently (except certain types allowed if enough time has passed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental eye drop for people with dry eye disease. It aims to see if the drops can reduce symptoms and signs of dry eye.
This study tests an investigational eye drop called OT202 to see if it helps people with moderate to severe dry eye. If you join, you'll receive either the study drug or a placebo (no active ingredient) and have your symptoms and eye health monitored for several months.
This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.
This trial tests a new eye drop (FBV_01) compared to a standard hyaluronic acid eye drop for people with moderate to severe dry eye. The goal is to see if the new drop provides better relief.
This trial tests whether 0.28% sodium hyaluronate eye drops can help people with moderate to severe dry eye feel better. It's for patients who have significant dry eye symptoms and signs on an eye exam.
This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.